Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Ligelizumab for Chronic Spontaneous Urticaria. Reply.

Center DM.

N Engl J Med. 2020 Feb 6;382(6):580. doi: 10.1056/NEJMc1915041. No abstract available.

PMID:
32023387
2.

A Better IgE Trap to Control Urticaria.

Center DM.

N Engl J Med. 2019 Oct 3;381(14):1376-1377. doi: 10.1056/NEJMe1907122. No abstract available.

PMID:
31577881
3.

Genomic medicine and lung diseases.

Center DM, Schwartz DA, Solway J, Gail D, Laposky AD, Lin QS, Gan W.

Am J Respir Crit Care Med. 2012 Aug 1;186(3):280-5. doi: 10.1164/rccm.201203-0569WS. Epub 2012 May 31. Review.

4.

Loss of nuclear pro-IL-16 facilitates cell cycle progression in human cutaneous T cell lymphoma.

Curiel-Lewandrowski C, Yamasaki H, Si CP, Jin X, Zhang Y, Richmond J, Tuzova M, Wilson K, Sullivan B, Jones D, Ryzhenko N, Little F, Kupper TS, Center DM, Cruikshank WW.

J Clin Invest. 2011 Dec;121(12):4838-49. doi: 10.1172/JCI41769. Epub 2011 Nov 14. Retraction in: J Clin Invest. 2014 Nov;124(11):5085.

5.

A genome-wide association study of plasma total IgE concentrations in the Framingham Heart Study.

Granada M, Wilk JB, Tuzova M, Strachan DP, Weidinger S, Albrecht E, Gieger C, Heinrich J, Himes BE, Hunninghake GM, Celedón JC, Weiss ST, Cruikshank WW, Farrer LA, Center DM, O'Connor GT.

J Allergy Clin Immunol. 2012 Mar;129(3):840-845.e21. doi: 10.1016/j.jaci.2011.09.029. Epub 2011 Nov 9.

6.

Topical diclofenac for sprains? These doctors say No.

Center DM, Migliorino R.

J Fam Pract. 2011 May;60(5):250-1; author reply 251. No abstract available.

PMID:
21695834
7.

Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy.

Green DS, Center DM, Cruikshank WW.

J Virol. 2009 Jun;83(11):5765-72. doi: 10.1128/JVI.00130-09. Epub 2009 Mar 18.

8.

Measurement of interleukin 16.

Center DM, Cruikshank WW, Parada NA, Ryan T, Theodore AC, Viglianti G, Lim KG, Weller PF.

Curr Protoc Immunol. 2001 May;Chapter 6:Unit 6.23. doi: 10.1002/0471142735.im0623s22.

PMID:
18432814
9.

Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP.

Zhang Y, Tuzova M, Xiao ZX, Cruikshank WW, Center DM.

J Immunol. 2008 Jan 1;180(1):402-8.

10.

Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model.

Morgan RK, McAllister B, Cross L, Green DS, Kornfeld H, Center DM, Cruikshank WW.

J Immunol. 2007 Jun 15;178(12):8081-9.

11.

Taking the "idio" out of idiopathic pulmonary fibrosis: a call to arms.

Center DM.

Am J Respir Crit Care Med. 2007 Jun 1;175(11):1101-2. No abstract available.

PMID:
17519345
12.

Chemokine receptor CXCR3 desensitization by IL-16/CD4 signaling is dependent on CCR5 and intact membrane cholesterol.

Rahangdale S, Morgan R, Heijens C, Ryan TC, Yamasaki H, Bentley E, Sullivan E, Center DM, Cruikshank WW.

J Immunol. 2006 Feb 15;176(4):2337-45.

13.

Association of asthma with a functional promoter polymorphism in the IL16 gene.

Burkart KM, Barton SJ, Holloway JW, Yang IA, Cakebread JA, Cruikshank W, Little F, Jin X, Farrer LA, Clough JB, Keith TP, Holgate S, Center DM, O'Connor GT.

J Allergy Clin Immunol. 2006 Jan;117(1):86-91.

PMID:
16387589
14.

Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.

Wilson KC, Cattel DJ, Wan Z, Rahangdale S, Ren F, Kornfeld H, Sullivan BA, Cruikshank WW, Center DM.

Cell Immunol. 2005 Sep;237(1):17-27. Epub 2005 Nov 9.

PMID:
16289056
15.

The effect of interleukin-16 and its precursor on T lymphocyte activation and growth.

Wilson KC, Center DM, Cruikshank WW.

Growth Factors. 2004 Jun;22(2):97-104. Review.

PMID:
15253385
16.
17.

Cutting edge: IL-16/CD4 preferentially induces Th1 cell migration: requirement of CCR5.

Lynch EA, Heijens CA, Horst NF, Center DM, Cruikshank WW.

J Immunol. 2003 Nov 15;171(10):4965-8.

18.

Immunomodulatory cytokines in asthmatic inflammation.

Lynch EL, Little FF, Wilson KC, Center DM, Cruikshank WW.

Cytokine Growth Factor Rev. 2003 Dec;14(6):489-502. Review.

PMID:
14563351
19.

Induced sputum analysis for T helper type 2 cell regulation: closing the loop.

Little FF, Center DM.

Chest. 2003 Jun;123(6):1786-8. No abstract available.

PMID:
12796149
20.

Immunomodulatory effect of interleukin-16 on allergic airway inflammation.

Little FF, de Bie J, van Oosterhout A, Kornfeld H, Center DM, Cruikshank WW.

Chest. 2003 Mar;123(3 Suppl):431S-2S. Review. No abstract available.

PMID:
12629022
21.

Binding of HTLV-1 tax oncoprotein to the precursor of interleukin-16, a T cell PDZ domain-containing protein.

Wilson KC, Center DM, Cruikshank WW, Zhang Y.

Virology. 2003 Feb 1;306(1):60-7.

22.

Tumor necrosis factor-alpha-induced synthesis of interleukin-16 in airway epithelial cells: priming for serotonin stimulation.

Little FF, Lynch E, Fine G, Center DM, Cruikshank WW.

Am J Respir Cell Mol Biol. 2003 Mar;28(3):354-62.

PMID:
12594062
23.

Differential roles of IL-16 and CD28/B7 costimulation in the generation of T-lymphocyte chemotactic activity in the bronchial mucosa of mild and moderate asthmatic individuals.

Dent G, Hosking LA, Lordan JL, Steel MD, Cruikshank WW, Center DM, Ellis JH, Holgate ST, Davies DE, Djukanović R.

J Allergy Clin Immunol. 2002 Dec;110(6):906-14.

PMID:
12464958
24.

Prointerleukin-16 contains a functional CcN motif that regulates nuclear localization.

Wilson KC, Cruikshank WW, Center DM, Zhang Y.

Biochemistry. 2002 Dec 3;41(48):14306-12.

PMID:
12450396
25.

Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells.

Gantner F, Sakai K, Tusche MW, Cruikshank WW, Center DM, Bacon KB.

J Pharmacol Exp Ther. 2002 Oct;303(1):300-7.

PMID:
12235264
26.

IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.

Bandeira-Melo C, Sugiyama K, Woods LJ, Phoofolo M, Center DM, Cruikshank WW, Weller PF.

J Immunol. 2002 May 1;168(9):4756-63.

27.

Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells.

Little FF, Cruikshank WW, Center DM.

Am J Respir Cell Mol Biol. 2001 Sep;25(3):347-52.

PMID:
11588013
28.

Lipopolysaccharide binding protein potentiates airway reactivity in a murine model of allergic asthma.

Strohmeier GR, Walsh JH, Klings ES, Farber HW, Cruikshank WW, Center DM, Fenton MJ.

J Immunol. 2001 Feb 1;166(3):2063-70.

29.

Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56lck enzymatic activity.

Van Drenth C, Jenkins A, Ledwich L, Ryan TC, Mashikian MV, Brazer W, Center DM, Cruikshank WW.

J Immunol. 2000 Dec 1;165(11):6356-63.

30.

Nuclear translocation of the N-terminal prodomain of interleukin-16.

Zhang Y, Kornfeld H, Cruikshank WW, Kim S, Reardon CC, Center DM.

J Biol Chem. 2001 Jan 12;276(2):1299-303.

31.

A role for the alveolar epithelium in recruitment of mononuclear cells into the lung.

Center DM.

J Clin Invest. 2000 Sep;106(6):741-3. No abstract available.

32.

Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma.

Laberge S, Pinsonneault S, Varga EM, Till SJ, Nouri-Aria K, Jacobson M, Cruikshank WW, Center DM, Hamid Q, Durham SR.

J Allergy Clin Immunol. 2000 Aug;106(2):293-301.

PMID:
10932073
33.

Interleukin 16 and T-cell chemoattractant activity in bronchoalveolar lavage 24 hours after allergen challenge in asthma.

Krug N, Cruikshank WW, Tschernig T, Erpenbeck VJ, Balke K, Hohlfeld JM, Center DM, Fabel H.

Am J Respir Crit Care Med. 2000 Jul;162(1):105-11.

PMID:
10903228
34.

Interleukin-16.

Cruikshank WW, Kornfeld H, Center DM.

J Leukoc Biol. 2000 Jun;67(6):757-66. Review.

PMID:
10857846
35.

Interleukin 16: implications for CD4 functions and HIV-1 progression.

Center DM, Kornfeld H, Ryan TC, Cruikshank WW.

Immunol Today. 2000 Jun;21(6):273-80. Review.

PMID:
10825739
36.
37.

Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES.

Hidi R, Riches V, Al-Ali M, Cruikshank WW, Center DM, Holgate ST, Djukanovic R.

J Immunol. 2000 Jan 1;164(1):412-8.

38.

Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis.

Yamasaki H, Ando M, Brazer W, Center DM, Cruikshank WW.

J Immunol. 1999 Sep 15;163(6):3516-23.

39.

Reciprocal desensitization of CCR5 and CD4 is mediated by IL-16 and macrophage-inflammatory protein-1 beta, respectively.

Mashikian MV, Ryan TC, Seman A, Brazer W, Center DM, Cruikshank WW.

J Immunol. 1999 Sep 15;163(6):3123-30.

40.

Identification of domains in IL-16 critical for biological activity.

Nicoll J, Cruikshank WW, Brazer W, Liu Y, Center DM, Kornfeld H.

J Immunol. 1999 Aug 15;163(4):1827-32.

41.

Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation.

Liu Y, Cruikshank WW, O'Loughlin T, O'Reilly P, Center DM, Kornfeld H.

J Biol Chem. 1999 Aug 13;274(33):23387-95.

42.

Phenotype of IL-16-producing cells in bronchial mucosa: evidence for the human eosinophil and mast cell as cellular sources of IL-16 in asthma.

Laberge S, Pinsonneault S, Ernst P, Olivenstein R, Ghaffar O, Center DM, Hamid Q.

Int Arch Allergy Immunol. 1999 Jun;119(2):120-5.

PMID:
10394103
43.

Processing and release of IL-16 from CD4+ but not CD8+ T cells is activation dependent.

Wu DM, Zhang Y, Parada NA, Kornfeld H, Nicoll J, Center DM, Cruikshank WW.

J Immunol. 1999 Feb 1;162(3):1287-93.

44.

Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis.

Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DY, Hamid Q.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):645-50.

PMID:
9802374
45.

Tissue and T cell distribution of precursor and mature IL-16.

Chupp GL, Wright EA, Wu D, Vallen-Mashikian M, Cruikshank WW, Center DM, Kornfeld H, Berman JS.

J Immunol. 1998 Sep 15;161(6):3114-9.

46.

Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients.

Mashikian MV, Tarpy RE, Saukkonen JJ, Lim KG, Fine GD, Cruikshank WW, Center DM.

J Allergy Clin Immunol. 1998 Jun;101(6 Pt 1):786-92.

PMID:
9648706
47.

Signaling and functional properties of interleukin-16.

Cruikshank WW, Kornfeld H, Center DM.

Int Rev Immunol. 1998;16(5-6):523-40. Review.

PMID:
9646175
48.

Conservation of structure and function between human and murine IL-16.

Keane J, Nicoll J, Kim S, Wu DM, Cruikshank WW, Brazer W, Natke B, Zhang Y, Center DM, Kornfeld H.

J Immunol. 1998 Jun 15;160(12):5945-54.

49.

CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10.

Biddison WE, Cruikshank WW, Center DM, Pelfrey CM, Taub DD, Turner RV.

J Immunol. 1998 Jan 1;160(1):444-8.

50.

Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma.

Hessel EM, Cruikshank WW, Van Ark I, De Bie JJ, Van Esch B, Hofman G, Nijkamp FP, Center DM, Van Oosterhout AJ.

J Immunol. 1998 Mar 15;160(6):2998-3005.

Supplemental Content

Loading ...
Support Center